Skip to content
Review

Exploring the broader social value outcomes reported in economic evaluations of vaccination programmes across the life course: A scoping review.

Oct 2026 · Vaccine · Vol 94, pp. 129226 · 0 citations · 65 references
Medicine

TL;DR

Economic evaluations of immunisation programmes continue to underrepresent the full multidimensional value of vaccination, with limited incorporation of broader social, economic, and life-course impacts.

Abstract

Background

Conventional economic evaluations typically focus on direct healthcare costs and quality-adjusted life years (QALYs), potentially underestimating the full value of vaccination.

Objective

This scoping review aimed to identify the broader outcomes captured in economic analyses of vaccination programmes.

Methods

A scoping review was conducted to explore the broader social, economic, and environmental values reported in economic analysis studies of vaccination programmes and strategies. Peer-reviewed and grey literature were systematically searched, and relevant studies were synthesised.

Results

A total of 8442 records were retrieved, with 171 articles included following full-text screening. Five categories of broader-value outcomes were identified, including short- and long-term productivity impacts, sequelae-related outcomes (e.g., long-term care needs), out-of-pocket expenses, and other wider economic and societal impacts.

Conclusions

Economic evaluations of immunisation programmes continue to underrepresent the full multidimensional value of vaccination, with limited incorporation of broader social, economic, and life-course impacts. Expanding the inclusion of these outcomes will strengthen the evidence base and support more informed, holistic decision-making for immunisation investment.

View source

Similar papers

Review Open access Sep 2026

Economic and productivity outcomes of workplace health programmes incorporating blood-based laboratory screening: a systematic review

Workplace health programmes increasingly include blood-based laboratory screening, promoted to lower costs and improve productivity, yet the economic case is contested and previous reviews have not isolated programmes with a blood-based screening component. We systematically reviewed the economic and productivity outco...

Dominik Swadźba, S. Makuch, Siddarth Agrawal · 0 citations
Review Open access Oct 2026

Health impacts of US international economic sanctions: a scoping review

Abstract Objectives There is growing concern about potential deleterious health impacts from international economic sanctions imposed by the USA. We summarised the existing research on the health impacts of US-imposed international economic sanctions. Design Scoping review. Data sources PubMed, Embase, PsycINFO, EconLi...

Deborah Korenstein, Christopher Schou, Emily N. Lum et al. · 0 citations
Review Open access Sep 2026

Supply, demand and use of economic evidence in vaccine policymaking in Africa: A scoping review

A sparse but growing literature of economic evaluations related to vaccine interventions in Africa is identified, with only a handful of countries represented in the articles published, implying a very low production of (and likely a low demand for) economic evaluation evidence.

Esther Mazuba, J. Kazibwe, Joseph Chirwa et al. · 0 citations
Review Open access Sep 2026

Economic Evaluations of Physical Exercise at Work: A Scoping Review.

PURPOSE Despite the well-established positive benefits of physical activity and the recognised consequences of physical inactivity, evidence on its cost and cost-effectiveness remains inconclusive. This scoping review aims to descriptively summarise studies on economic evaluations of workplace physical exercise interve...

Juan Andres Pozzi, L. F. Sandal, Brent D. Leininger et al. · 0 citations
Review Open access Oct 2026

New framework and global evidence for the economic aspects of climate-mental health actions

Abstract Introduction Currently, mental health is not well integrated in climate policies, linked public health strategies, and climate adaptation and mitigation efforts. Evidence on associated economic burden, economic value of actions and financing remains limited. Methods We developed a multi-sectoral conceptual fra...

J. Simon, S. Diexer, N. Perić et al. · 0 citations
Open access Sep 2026

Economic Evaluation of an Indicated Prevention Strategy Focused on Future Long-Term Sickness Absence.

The economic evaluation showed that the IPS had an economic benefit over the care as usual, as seen from the employer's perspective, which indicates a way towards a balanced comparison of preventive interventions, which is to prioritize the most relevant preventive actions.

Sophie H. Klasen, L. V. van Amelsvoort, IJmert Kant et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.